Huida suffered a rare downgrade: Baird cut its target price to US$200, and Morgan Stanley also removed it from its top pick
Baird lowered Huida to neutral and cut its target price from US$500 to US$200. It is estimated that the new ban on H200 may bring about US$5 billion in write-downs; Morgan Stanley and Bank of America removed Huida from the recommendation list on the same day. This article Huida suffered a rare downgrade: Baird’s target price was cut to US$200, and Morgan Stanley also removed its top choice. First appeared on Chain News ABMedia.
Read more










